Prevena Central for plastic surgery

Prevena Central for plastic surgery

The Power to Protect with 3M™ Prevena™ Therapy

Request a Trial

Prevena Therapy is designed to manage and help protect the surgical incision and reduce the risk of surgical site complications to improve patient outcomes across multiple surgical specialties.1-11 This can also help to reduce the burden on healthcare facilities through reduced reoperations 2,5,8 and associated additional costs of treatment.10,11,

Prevena Therapy demonstrates reduction in Surgical Site Complications (SSCs) vs Standard of Care (SOC)
  • In a prospective, single-center, randomized controlled trial with patients undergoing breast reconstruction, Prevena Therapy aided in:

  • round purple and grey icon saying 47%

    Reduction in SSCs8*

    90-day post-operatively
    8.5% (28/331) Prevena Therapy vs.
    15.9% (53/334) SOC (p=0.0092)*

  • round purple and grey icon saying 53%

    Reduction in SSIs8*

    90-day post-operatively
    2.1% (7/331) Prevena Therapy vs.
    4.5% (15/334) SOC (p=0.0225)

  • round purple and grey icon saying 68%

    Reduction in seroma8*

    90-days post-operatively
    1.8% (6/331) Prevena Therapy vs.
    5.7% (19/334) SOC (p=0.0106)*

  • Calculations are derived based on relative patient group incidence rate reported in this study.

    *Statistically significant (p<0.05).

Prevena Central horizontal rule
Prevena Central horizontal rule

Proactive Risk Management (PRM) with Prevena Therapy

Implement PRM to help protect your high-risk patients. See the evidence behind the use of Prevena Therapy in plastic surgery.

Prevena Central horizontal rule
purple banner

Request a trial today

Contact us to request a trial and consultation with a 3M clinical specialist


Surgeon testimonials

Prevena Central horizontal rule

Peer reviewed clinical evidence

Prevena Central horizontal rule

Application videos

Prevena Central horizontal rule
dark blue banner

Ready to try Prevena Therapy?

  • Thank you for your request to 3M. The information you provide on this form will be used to respond to your request through email or telephone by a 3M representative or by one of our authorised business partners with whom we might share your personal information consistent with the 3M privacy policy.

    Please provide your information about your professional interest as we'd like to make sure you only recieve information from 3M that is interesting and relevant to you

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

Our apologies...

An error has occurred while submitting. Please try again later

Thank you!

Your form was submitted successfully

NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.


  1. Ferrando PM, Ala A, Bussone R, Bergamasco L, Actis Perinetti F, Malan F. Closed incision negative pressure therapy in oncological breast surgery: comparison with standard care dressings. Plast Reconstr Surg Glob Open. 2018 Jun 15;6(6):e1732. doi:10.1097/GOX000000000000173
  2. Pleger SP, Nink N, Elzien M, Kunold A, Koshty A, Boning A. Reduction of groin wound complications in vascular surgery patients using closed incision negative pressure therapy (ciNPT): a prospective, randomised, single-institution study. Int Wound J. 2018;15(1):75-83.
  3. Cooper HJ, Bas MA. Closed-incision negative-pressure therapy versus antimicrobial dressings after revision hip and knee surgery: a comparative study. J Arthroplasty. 2016 May;31(5):1047-1052. doi:10.1016/j.arth.2015.11.010
  4. Redfern RE, Cameron-Ruetz C, O’Drobinak SK, Chen JT, Beer KJ. Closed incision negative pressure therapy effects on postoperative infection and surgical site complication after total hip and knee arthroplasty. J Arthroplasty. 2017;32:3333-3339. doi:10.1016/j.arth.2017.06.019
  5. Newman JM, Siqueira MBP, Klika AK, Molloy RM, Barsoum WK, Higuera CA. Use of closed incisional negative pressure wound therapy after revision total hip and knee arthroplasty in patients at high risk for infection: a prospective, randomized clinical trial. J Arthroplasty. 2019 Mar;34(3):554-559e1. doi:10.1016/j.arth.2018
  6. Stannard JP, Volgas DA, McGwin G 3rd, et al. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma. 2012;26(1):37‐42. doi:10.1097/BOT.0b013e318216b1e5.
  7. Grauhan O, Navasardyan A, Hofmann M, et al. Prevention of poststernotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013;145:1387-1392.
  8. Gabriel A, Sigalove S, Sigalove N, et al. The impact of closed incision negative pressure therapy on postoperative breast reconstruction outcomes. Plast Reconstr Surg Glob Open. 2018 Aug; 6(8): e1880.doi:10.1097/GOX.0000000000001880
  9. Stannard JP, Volgas DA, McGwin G 3rd, et al. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma. 2012;26(1):37‐42. doi:10.1097/BOT.0b013e318216b1e5.
  10. Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B, Salvatore D, Reiter D, DiMuzio P. A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg. 2018 Dec;68(6):1744-1752. doi: 10.1016/j.jvs.2018.05.224. Epub 2018 Aug 17. PMID: 30126781.
  11. Gabriel A, Maxwell GP. Economic Analysis Based on the Use of Closed-Incision Negative-Pressure Therapy after Postoperative Breast Reconstruction. Plast Reconstr Surg. 2019 Jan;143(1S Management of Surgical Incisions Utilizing Closed-Incision Negative-Pressure Therapy):36S-40S. doi: 1097/PRS.0000000000005311. PMID: 30586102.